The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations
Open accessAbstract
(TIbV), defined as vaccine formulations that induce training in innate immune cells. Unlike conventional vaccines, which are aimed to elicit only specific responses to vaccine-related antigens, TIbV aim to stimulate broader responses. As trained immunity is generally triggered by pattern recognition receptors (PRRs), TIbV should be formulated with microbial structures containing suitable PRR-ligands. The TIbV concept we describe here may be used for the development of vaccines focused to promote host resistance against a wide spectrum of pathogens. Under the umbrella of trained immunity, a broad protection can be achieved by: (i) increasing the nonspecific effector response of innate immune cells (e.g., monocyte/macrophages) to pathogens, (ii) harnessing the activation state of dendritic cells to enhance adaptive T cell responses to both specific and nonrelated (bystander) antigens. This capacity of TIbV to promote responses beyond their nominal antigens may be particularly useful when conventional vaccines are not available or when multiple coinfections and/or recurrent infections arise in susceptible individuals. As the set of PRR-ligands chosen is essential not only for stimulating trained immunity but also to drive adaptive immunity, the precise design of TIbV will improve with the knowledge on the functional relationship among the different PRRs. While the TIbV concept is emerging, a number of the current anti-infectious vaccines, immunostimulants, and even vaccine adjuvants may already fall in the TIbV category. This may apply to increase immunogenicity of novel vaccine design approaches based on small molecules, like those achieved by reverse vaccinology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Self-citationmTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224
Self-citationThe epidemiology of urinary tract infection
Foxman, B. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.190 · Cited by 1,771
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
Saeed, S., Quintin, J., Kerstens, H. H. D., Rao, N. A., Aghajanirefah, A., Matarese, F., Cheng, S.-C., Ratter, J., Berentsen, K., van der Ent, M. A., et al. (2014) · Science · doi:10.1126/science.1251086 · Cited by 1,761
Self-citationKleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L. A. B., Ifrim, D. C., Saeed, S., Jacobs, C., van Loenhout, J., de Jong, D., Stunnenberg, H. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202870109 · Cited by 1,728 · cited 3×
“Interestingly, although a maximum duration of trained immunity effects has been reported up to 3 months (24), a long lasting effect of trained cells with the capacity to enhance T cell responses up to 1 year is feasible (26), thus bridging innate training with adaptive responses.”
BackgroundSelf-citationTrained Immunity: A Memory for Innate Host Defense
Netea, M. G., Quintin, J., & van der Meer, J. W. M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.04.006 · Cited by 1,682
Self-citationQuintin, J., Saeed, S., Martens, J. H. A., Giamarellos-Bourboulis, E. J., Ifrim, D. C., Logie, C., Jacobs, L., Jansen, T., Kullberg, B.-J., Wijmenga, C., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.006 · Cited by 1,289
Self-citationBCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Kaufmann, E., Sanz, J., Dunn, J. L., Khan, N., Mendonça, L. E., Pacis, A., Tzelepis, F., Pernet, E., Dumaine, A., Grenier, J.-C., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.031 · Cited by 1,191
Arts, R. J. W., Moorlag, S. J. C. F. M., Novakovic, B., Li, Y., Wang, S.-Y., Oosting, M., Kumar, V., Xavier, R. J., Wijmenga, C., Joosten, L. A. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.010 · Cited by 1,179
Self-citationModulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Mitroulis, I., Ruppova, K., Wang, B., Chen, L.-S., Grzybek, M., Grinenko, T., Eugster, A., Troullinaki, M., Palladini, A., Kourtzelis, I., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.034 · Cited by 1,100
Self-citationWestern Diet Triggers NLRP3-Dependent Innate Immune Reprogramming
Christ, A., Günther, P., Lauterbach, M. A. R., Duewell, P., Biswas, D., Pelka, K., Scholz, C. J., Oosting, M., Haendler, K., Baßler, K., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.013 · Cited by 1,084
Self-citationInnate immune memory in the brain shapes neurological disease hallmarks
Wendeln, A.-C., Degenhardt, K., Kaurani, L., Gertig, M., Ulas, T., Jain, G., Wagner, J., Häsler, L. M., Wild, K., Skodras, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0023-4 · Cited by 956
Metabolic Induction of Trained Immunity through the Mevalonate Pathway
Bekkering, S., Arts, R. J. W., Novakovic, B., Kourtzelis, I., van der Heijden, C. D. C. C., Li, Y., Popa, C. D., ter Horst, R., van Tuijl, J., Netea-Maier, R. T., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.025 · Cited by 781
Self-citationGuillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M., & Si-Tahar, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410592200 · Cited by 689
Immunometabolic Pathways in BCG-Induced Trained Immunity
Arts, R. J. W., Carvalho, A., La Rocca, C., Palma, C., Rodrigues, F., Silvestre, R., Kleinnijenhuis, J., Lachmandas, E., Gonçalves, L. G., Belinha, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.011 · Cited by 683
Self-citationβ-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance
Novakovic, B., Habibi, E., Wang, S.-Y., Arts, R. J. W., Davar, R., Megchelenbrink, W., Kim, B., Kuznetsova, T., Kox, M., Zwaag, J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.034 · Cited by 680
Self-citationFungal β-Glucans and Mammalian Immunity
Brown, G. D., & Gordon, S. (2003) · Immunity · doi:10.1016/s1074-7613(03)00233-4 · Cited by 665
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Kleinnijenhuis, J., Quintin, J., Preijers, F., Benn, C. S., Joosten, L. A. B., Jacobs, C., van Loenhout, J., Xavier, R. J., Aaby, P., van der Meer, J. W. M., et al. (2014) · Journal of Innate Immunity · doi:10.1159/000355628 · Cited by 620
Self-citationAn endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
Zanoni, I., Tan, Y., Di Gioia, M., Broggi, A., Ruan, J., Shi, J., Donado, C. A., Shao, F., Wu, H., Springstead, J. R., et al. (2016) · Science · doi:10.1126/science.aaf3036 · Cited by 583
Aaby, P., Roth, A., Ravn, H., Napirna, B. M., Rodrigues, A., Lisse, I. M., Stensballe, L., Diness, B. R., Lausch, K. R., Lund, N., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir240 · Cited by 583
A small jab – a big effect: nonspecific immunomodulation by vaccines
Benn, C. S., Netea, M. G., Selin, L. K., & Aaby, P. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.004 · Cited by 514
Self-citationEpidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease
Cherry, J. D. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1209051 · Cited by 472
Lung Infection—A Public Health Priority
Mizgerd, J. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030076 · Cited by 290
Innate immune memory: An evolutionary perspective
Gourbal, B., Pinaud, S., Beckers, G. J. M., Van Der Meer, J. W. M., Conrath, U., & Netea, M. G. (2018) · Immunological Reviews · doi:10.1111/imr.12647 · Cited by 289
Self-citationOta, M. O. C., Vekemans, J., Schlegel-Haueter, S. E., Fielding, K., Sanneh, M., Kidd, M., Newport, M. J., Aaby, P., Whittle, H., Lambert, P.-H., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.919 · Cited by 288
Evidence for macrophage-mediated protection against lethal Candida albicans infection
Bistoni, F., Vecchiarelli, A., Cenci, E., Puccetti, P., Marconi, P., & Cassone, A. (1986) · Infection and Immunity · doi:10.1128/iai.51.2.668-674.1986 · Cited by 285
Kloepfer, K. M., Lee, W. M., Pappas, T. E., Kang, T. J., Vrtis, R. F., Evans, M. D., Gangnon, R. E., Bochkov, Y. A., Jackson, D. J., Lemanske, R. F., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.030 · Cited by 274
Harnessing the beneficial heterologous effects of vaccination
Goodridge, H. S., Ahmed, S. S., Curtis, N., Kollmann, T. R., Levy, O., Netea, M. G., Pollard, A. J., van Crevel, R., & Wilson, C. B. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.43 · Cited by 258
Self-citationInnate immune memory: towards a better understanding of host defense mechanisms
Quintin, J., Cheng, S.-C., van der Meer, J. W., & Netea, M. G. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.02.006 · Cited by 247
Self-citationNon-specific effects of vaccines: Current evidence and potential implications
de Bree, L. C. J., Koeken, V. A. C. M., Joosten, L. A. B., Aaby, P., Benn, C. S., van Crevel, R., & Netea, M. G. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.06.002 · Cited by 231
Self-citationPrevention and cure of rotavirus infection via TLR5/NLRC4–mediated production of IL-22 and IL-18
Zhang, B., Chassaing, B., Shi, Z., Uchiyama, R., Zhang, Z., Denning, T. L., Crawford, S. E., Pruijssers, A. J., Iskarpatyoti, J. A., Estes, M. K., et al. (2014) · Science · doi:10.1126/science.1256999 · Cited by 230
Buffen, K., Oosting, M., Quintin, J., Ng, A., Kleinnijenhuis, J., Kumar, V., van de Vosse, E., Wijmenga, C., van Crevel, R., Oosterwijk, E., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004485 · Cited by 229
Self-citationInfection in an aging population
Kline, K. A., & Bowdish, D. M. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.11.003 · Cited by 228
Clonal dissection of the human memory B‐cell repertoire following infection and vaccination
Pinna, D., Corti, D., Jarrossay, D., Sallusto, F., & Lanzavecchia, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200839129 · Cited by 224
COLLET, J. P., SHAPIRO, S., ERNST, P., RENZI, P., DUCRUET, T., ROBINSON, A., & the PARI-IS Study Steering Committee and Research Group (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9612096 · Cited by 221
Mayer-Barber, K. D., & Yan, B. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.25 · Cited by 213
Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines
Blok, B. A., Arts, R. J. W., van Crevel, R., Benn, C. S., & Netea, M. G. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ri0315-096r · Cited by 211
Self-citationImmunological memory: lessons from the past and a look to the future
Farber, D. L., Netea, M. G., Radbruch, A., Rajewsky, K., & Zinkernagel, R. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.13 · Cited by 200
Self-citationThe immunostimulant OM-85 BV prevents wheezing attacks in preschool children
Razi, C. H., Harmancı, K., Abacı, A., Özdemir, O., Hızlı, Ş., Renda, R., & Keskin, F. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.07.038 · Cited by 178
The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders
Arts, R. J. W., Joosten, L. A. B., & Netea, M. G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00298 · Cited by 177
Self-citationInduction of innate immune memory: the role of cellular metabolism
Domínguez‐Andrés, J., Joosten, L. A. B., & Netea, M. G. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.001 · Cited by 173
Self-citationLouis Pasteur, the father of immunology?
Smith, K. A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00068 · Cited by 172
Immunological memory within the innate immune system
Sun, J. C.-Y., Ugolini, S., & Vivier, É. (2014) · The EMBO Journal · doi:10.1002/embj.201387651 · Cited by 170
Kawai, K., Miyazaki, J., Joraku, A., Nishiyama, H., & Akaza, H. (2013) · Cancer Science · doi:10.1111/cas.12075 · Cited by 168
Mucosal Administration of Flagellin Protects Mice from Streptococcus pneumoniae Lung Infection
Muñoz‐Wolf, N., Maele, L. V., Marqués, J. M., Rial, A., Sirard, J., & Chabalgoity, J. A. (2010) · Infection and Immunity · doi:10.1128/iai.00224-10 · Cited by 165
How Inflammasomes Inform Adaptive Immunity
Evavold, C. L., & Kagan, J. C. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.019 · Cited by 164
Smith, S. A., Zhou, Y., Olivarez, N. P., Broadwater, A. H., de Silva, A. M., & Crowe, J. E. (2012) · Journal of Virology · doi:10.1128/jvi.06335-11 · Cited by 161
Leentjens, J., Bekkering, S., Joosten, L. A. B., Netea, M. G., Burgner, D. P., & Riksen, N. P. (2018) · Circulation Research · doi:10.1161/circresaha.117.312465 · Cited by 160
Self-citationDowling, D. J., Scott, E. A., Scheid, A., Bergelson, I., Joshi, S., Pietrasanta, C., Brightman, S. E., Sánchez‐Schmitz, G., van Haren, S. D., Ninković, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.12.985 · Cited by 147
Rizzetto, L., Ifrim, D. C., Moretti, S., Tocci, N., Cheng, S., Quintin, J., Renga, G., Oikonomou, V., Filippo, C. D., Weil, T., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.699645 · Cited by 146
Self-citationEsposito, S., Soto‐Martínez, M. E., Feleszko, W., Jones, M. H., Shen, K., & Schaad, U. B. (2018) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000433 · Cited by 146
Schleicher, U., Paduch, K., Debus, A., Obermeyer, S., König, T., Kling, J. C., Ribechini, E., Dudziak, D., Mougiakakos, D., Murray, P. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.001 · Cited by 136
Gillard, G. O., Bivas‐Benita, M., Hovav, A., Grandpre, L. E., Panas, M. W., Seaman, M. S., Haynes, B. F., & Letvin, N. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002141 · Cited by 136
Innate immune memory: Implications for host responses to damage‐associated molecular patterns
Crișan, T. O., Netea, M. G., & Joosten, L. A. B. (2016) · European Journal of Immunology · doi:10.1002/eji.201545497 · Cited by 131
Self-citationPiedra, P. A., Gaglani, M., Kozinetz, C. A., Herschler, G. B., Fewlass, C., Harvey, D., Zimmerman, N., & Glezen, W. P. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2836 · Cited by 124
Novel Platforms for the Development of a Universal Influenza Vaccine
Kumar, A., Meldgaard, T. S., & Bertholet, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00600 · Cited by 115
Gutiérrez-Tarango, M. D., & Berber, A. C. (2001) · CHEST Journal · doi:10.1378/chest.119.6.1742 · Cited by 112
Lorenzo-Gómez, M. F., Padilla-Fernández, B. Y., García‐Criado, F. J., Canelo, J. A. M., Gil-Vicente, A., Nieto-Huertos, A., & Silva-Abuín, J. M. (2012) · International Urogynecology Journal · doi:10.1007/s00192-012-1853-5 · Cited by 103
Dectin-1 plays a redundant role in the immunomodulatory activities of β-glucan-rich ligands in vivo
Marakalala, M. J., Williams, D. L., Hoving, J. C., Engstad, R. E., Netea, M. G., & Brown, G. D. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.03.002 · Cited by 103
Self-citationEffects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice
Krahenbuhl, J. L., Sharma, S., Ferraresi, R. W., & Remington, J. S. (1981) · Infection and Immunity · doi:10.1128/iai.31.2.716-722.1981 · Cited by 101
Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease
Wilson, R., Sethi, S., Anzueto, A., & Miravitlles, M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.08.010 · Cited by 87
The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future
Tso, G. H. W., Reales‐Calderón, J. A., & Pavelka, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00897 · Cited by 86
Leentjens, J., Quintin, J., Gerretsen, J., Kox, M., Pickkers, P., & Netea, M. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108794 · Cited by 83
Self-citationVaccinia scars associated with better survival for adults
Aaby, P., Gustafson, P., Roth, A., Rodrigues, A., Fernandes, M., Sodemann, M., Holmgren, B., Benn, C. S., Garly, M., Lisse, I. M., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.045 · Cited by 81
Pasquali, C., Salami, O., Taneja, M., Gollwitzer, E. S., Trompette, A., Pattaroni, C., Yadava, K., Bauer, J., & Marsland, B. J. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00041 · Cited by 81
Benito‐Villalvilla, C., Cirauqui, C., Diez-Rivero, C. M., Casanovas, M., Subiza, J. L., & Palomares, Ó. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.112 · Cited by 81
Self-citationPneumococcal whole-cell and protein-based vaccines: changing the paradigm
Pichichero, M. E. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1393335 · Cited by 80
Trained immunity as a novel therapeutic strategy
Mourits, V. P., Wijkmans, J. C., Joosten, L. A. B., & Netea, M. G. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.04.007 · Cited by 80
Self-citationCirauqui, C., Benito‐Villalvilla, C., Sánchez‐Ramón, S., Sirvent, S., Diez-Rivero, C. M., Conejero, L., Brandi, P., Hernández‐Cillero, L., Ochoa, J., Pérez‐Villamil, B., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201747024 · Cited by 71
Self-citationRibes, S., Meister, T., Ott, M., Redlich, S., Jáňová, H., Hanisch, U., Nessler, S., & Nau, R. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-14 · Cited by 68
Hoogeveen, R. M., Nahrendorf, M., Riksen, N. P., Netea, M. G., de Winther, M. P. J., Lutgens, E., Nordestgaard, B. G., Neidhart, M., Stroes, E. S. G., Catapano, A. L., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx581 · Cited by 68
Self-citationLee, Y. J., Lee, J. Y., Jang, Y. H., Seo, S., Chang, J., & Seong, B. L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00083 · Cited by 68
Chien, Y., Klugman, K. P., & Morens, D. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/657144 · Cited by 66
Norton, E. B., Clements, J. D., Voss, T. G., & Cárdenas-Freytag, L. (2010) · Journal of Virology · doi:10.1128/jvi.01805-09 · Cited by 62
Vaccinia Scars Associated with Improved Survival among Adults in Rural Guinea-Bissau
Jensen, M. L., Dave, S. S., van der Loeff, M. F. S., Costa, C. D. S., Vincent, T., Leligdowicz, A., Benn, C. S., Roth, A., Ravn, H., Lisse, I. M., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000101 · Cited by 59
Ndung’u, T., & Weiss, R. A. (2012) · AIDS · doi:10.1097/qad.0b013e32835461b5 · Cited by 56
Abdul-Careem, M. F., Mian, M. F., Gillgrass, A. E., Chenoweth, M. J., Barra, N. G., Chan, T., Al-Garawi, A. A., Chew, M. V., Yue, G., van Roojen, N., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.09.004 · Cited by 55
Kjærgaard, J., Birk, N. M., Nissen, T. N., Thøstesen, L. M., Pihl, G. T., Benn, C. S., Jeppesen, D. L., Pryds, O. A., Kofoed, P., Aaby, P., et al. (2016) · Pediatric Research · doi:10.1038/pr.2016.142 · Cited by 55
Taking Advantage of the Positive Side‐Effects of Smallpox Vaccination
Mayr, A. (2004) · Journal of Veterinary Medicine Series B · doi:10.1111/j.1439-0450.2004.00763.x · Cited by 52
Unravelling the nature of non-specific effects of vaccines—A challenge for innate immunologists
Jensen, K. J., Benn, C. S., & van Crevel, R. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.05.005 · Cited by 50
Scheid, A., Borriello, F., Pietrasanta, C., Christou, H. A., Diray‐Arce, J., Pettengill, M. A., Joshi, S., Li, N., Bergelson, I., Kollmann, T. R., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00029 · Cited by 40
de Bree, L. C. J., Marijnissen, R. J., Kel, J. M., Huber, S. K. R., Aaby, P., Benn, C. S., Wijnands, M. V. W., Diavatopoulos, D. A., van Crevel, R., Joosten, L. A. B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00869 · Cited by 40
Self-citationThe use of databases, data mining and immunoinformatics in vaccinology: where are we?
Hegde, N. R., Gauthami, S., Kumar, H. M. S., & Bayry, J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1413088 · Cited by 39
Mevalonate Metabolism in Cancer Stemness and Trained Immunity
Gruenbacher, G., & Thurnher, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00394 · Cited by 38
Breyne, K., Steenbrugge, J., Demeyere, K., Berghe, T. V., & Meyer, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00833 · Cited by 29
What if protective immunity is antigen—driven and not due to so‐called “memory” B and T cells?
Zinkernagel, R. M. (2018) · Immunological Reviews · doi:10.1111/imr.12648 · Cited by 27
In silico design of knowledge-based Plasmodium falciparum epitope ensemble vaccines
Damfo, S. A., Reche, P. A., Gatherer, D., & Flower, D. R. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.10.004 · Cited by 24
Chiavaroli, C., & Moore, A. (2006) · BioDrugs · doi:10.2165/00063030-200620030-00001 · Cited by 23
Pieraerts, C., Martin, V., Jichlinski, P., Nardelli‐Haefliger, D., & Derré, L. (2012) · OncoImmunology · doi:10.4161/onci.20526 · Cited by 15
Birk, N. M., Nissen, T. N., Kjærgaard, J., Hartling, H. J., Thøstesen, L. M., Kofoed, P., Stensballe, L. G., Andersen, A., Pryds, O. A., Netea, M. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11601-6 · Cited by 15
Self-citationFaure, F., Jouve, M. J., Péguillet, I., Sadaka, C., Sepulveda, F. E., Lantz, O. J., Berrè, S., Gaudin, R., Sánchez‐Ramón, S., & Amigorena, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.31037 · Cited by 14
Self-citationExtending the Clinical Horizons of Mucosal Bacterial Vaccines: Current Evidence and Future Prospects
Sánchez‐Ramón, S., de Diego, R. P., Dieli-Crimi, R., & Subiza, J. L. (2014) · Current Drug Targets · doi:10.2174/1389450115666141020160705 · Cited by 13
Self-citation
Cited by
Immunological considerations for COVID-19 vaccine strategies
Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015
Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
Thakur, A., Mikkelsen, H., & Jungersen, G. (2019) · Journal of Immunology Research · doi:10.1155/2019/1356540 · Cited by 396
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams, R. O. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01744-7 · Cited by 327
Overcoming immune dysfunction in the elderly: trained immunity as a novel approach
Bulut, O., Kilic, G., Domínguez-Andrés, J., & Netea, M. G. (2020) · International Immunology · doi:10.1093/intimm/dxaa052 · Cited by 99
Self-citation
Metadata
- Authors
- Sánchez-Ramón, S., Conejero, L., Netea, M. G., Sancho, D., Palomares, Ó., & Subiza, J. L.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-12-17
- Volume
- 9
- Pages
- 2936-2936
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2905235893
- Cited by
- 262
- References
- 94
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.